Accurate
Cutting-edge
To the point
Omics Express is a community-supported bioinformatic software project, and a consultancy.
We specialize in:
Our software projects have a successful track record in assisting important scientific and industrial breakthroughs.
FDA news on personalized medicine: FDA Approves Kalydeco to Treat
Rare Form of Cystic Fibrosis
The U.S. Food and Drug Administration today approved Kalydeco (ivacaftor)
for the treatment of a rare form of cystic fibrosis (CF) in patients ages
6 years and older who have the specific G551D mutation in the Cystic Fibrosis
Transmembrane Regulator (CFTR) gene.
CF is a serious genetic disorder affecting the lungs and other organs that
ultimately leads to an early death. It is caused by mutations (defects)
in a gene that encodes for a protein called CFTR that regulates ion (such
as chloride) and water transport in the body. The defect in chloride and
water transport results in the formation of thick mucus that builds up in
the lungs, digestive tract and other parts of the body leading to severe
respiratory and digestive problems, as well as other complications such
as infections and diabetes.
Full
story
Our software tools have contributed to significant amount of scientific
and commercial successes. These include:
Successful identification of the human IL28B variation
- a biomarker for hepatitis C treatment efficacy. This scientific breakthrough
was published in Nature in 2009, and the resulted clinical diagnostic
service has been provided to benefit the hepatitis C patients.
read more
